HCA Healthcare, Inc. (NYSE:HCA) Shares Bought by Fortem Financial Group LLC

Fortem Financial Group LLC boosted its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 2.0% in the second quarter, according to its most recent disclosure with the SEC. The firm owned 5,358 shares of the company’s stock after acquiring an additional 105 shares during the period. Fortem Financial Group LLC’s holdings in HCA Healthcare were worth $1,721,000 at the end of the most recent quarter.

Other institutional investors have also modified their holdings of the company. Atlantic Edge Private Wealth Management LLC purchased a new position in shares of HCA Healthcare in the fourth quarter worth about $27,000. Bangor Savings Bank grew its position in shares of HCA Healthcare by 112.5% in the second quarter. Bangor Savings Bank now owns 85 shares of the company’s stock valued at $27,000 after purchasing an additional 45 shares in the last quarter. MFA Wealth Advisors LLC purchased a new stake in shares of HCA Healthcare in the second quarter valued at about $27,000. Unique Wealth Strategies LLC acquired a new stake in shares of HCA Healthcare during the 2nd quarter worth about $28,000. Finally, GPS Wealth Strategies Group LLC lifted its position in HCA Healthcare by 284.0% in the second quarter. GPS Wealth Strategies Group LLC now owns 96 shares of the company’s stock valued at $31,000 after buying an additional 71 shares during the last quarter. Institutional investors and hedge funds own 62.73% of the company’s stock.

HCA Healthcare Trading Up 0.1 %

Shares of HCA opened at $395.98 on Wednesday. The firm’s 50-day moving average is $351.93 and its two-hundred day moving average is $334.46. The firm has a market capitalization of $103.71 billion, a P/E ratio of 19.74, a PEG ratio of 1.52 and a beta of 1.68. The company has a current ratio of 1.06, a quick ratio of 0.94 and a debt-to-equity ratio of 27.11. HCA Healthcare, Inc. has a twelve month low of $215.96 and a twelve month high of $397.73.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings data on Tuesday, July 23rd. The company reported $5.50 EPS for the quarter, beating analysts’ consensus estimates of $4.97 by $0.53. The firm had revenue of $17.49 billion for the quarter, compared to analysts’ expectations of $17.05 billion. HCA Healthcare had a net margin of 8.40% and a return on equity of 553.13%. The firm’s revenue was up 10.3% on a year-over-year basis. During the same period in the prior year, the company earned $4.29 EPS. On average, research analysts predict that HCA Healthcare, Inc. will post 22.5 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, September 30th. Stockholders of record on Monday, September 16th will be issued a dividend of $0.66 per share. This represents a $2.64 annualized dividend and a dividend yield of 0.67%. The ex-dividend date is Monday, September 16th. HCA Healthcare’s dividend payout ratio (DPR) is 13.16%.

Wall Street Analysts Forecast Growth

A number of equities analysts recently weighed in on HCA shares. JPMorgan Chase & Co. increased their price objective on shares of HCA Healthcare from $327.00 to $332.00 and gave the stock a “neutral” rating in a research report on Thursday, May 30th. Oppenheimer raised their target price on HCA Healthcare from $345.00 to $390.00 and gave the company an “outperform” rating in a report on Wednesday, July 24th. Robert W. Baird assumed coverage on HCA Healthcare in a research report on Thursday, May 30th. They set an “outperform” rating and a $396.00 price objective on the stock. UBS Group upped their price target on HCA Healthcare from $405.00 to $438.00 and gave the stock a “buy” rating in a report on Wednesday, August 14th. Finally, Wolfe Research raised HCA Healthcare to a “strong-buy” rating in a report on Thursday, August 29th. Five research analysts have rated the stock with a hold rating, fourteen have given a buy rating and three have issued a strong buy rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $359.89.

Insiders Place Their Bets

In related news, SVP Christopher F. Wyatt sold 4,000 shares of the business’s stock in a transaction that occurred on Monday, July 29th. The shares were sold at an average price of $360.20, for a total value of $1,440,800.00. Following the completion of the sale, the senior vice president now directly owns 40,449 shares in the company, valued at $14,569,729.80. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. In related news, SVP Christopher F. Wyatt sold 4,000 shares of HCA Healthcare stock in a transaction on Monday, July 29th. The stock was sold at an average price of $360.20, for a total value of $1,440,800.00. Following the transaction, the senior vice president now owns 40,449 shares in the company, valued at $14,569,729.80. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, SVP Kathleen M. Whalen sold 2,987 shares of the business’s stock in a transaction dated Wednesday, July 31st. The stock was sold at an average price of $363.51, for a total value of $1,085,804.37. Following the sale, the senior vice president now owns 9,454 shares of the company’s stock, valued at approximately $3,436,623.54. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 8,844 shares of company stock valued at $3,185,932. Insiders own 1.60% of the company’s stock.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.